EventsThe 2nd International Conference on Bioengineering
Published
This submission belongs to the session S3. Biosignal Processing of the event The 2nd International Conference on Bioengineering
Published date
16 Nov, 2026
Contribution&Funding
Conceptualization,
[Jin-Woo Oh] ; [Cheol Woong Choi] ; [Hyung Woo Lee]
Formal analysis,
[Cheol Woong Choi] ; [Hyung Woo Lee]
Supervision,
[Jin-Woo Oh]
Project administration,
[Jin-Woo Oh]
Funding: This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (No. RS-2024-00406152).
Citation
Jin-Woo Oh, Cheol Woong Choi, Hyung Woo Lee, Self-Assembled Bio–Metal Hybrid Film for SERS-Based Serum Metabolite Profiling and Gastric Cancer Diagnosis, in Proceedings of The 2nd International Conference on Bioengineering, Barcelona, 10 November–13 November 2026, MDPI: Basel, Switzerland
Share
Email
Facebook
Twitter
LinkedIn

Self-Assembled Bio–Metal Hybrid Film for SERS-Based Serum Metabolite Profiling and Gastric Cancer Diagnosis

1. Humanoid Olfactory Display Innovation Research Center, Pusan National University, Pusan, 46241, South Korea
2. Department of Nano Fusion Technology, Pusan National University, Pusan, 46241, South Korea
3. Executive Office, JENLiFE CO., LTD., Yangsan, 50612, South Korea
4. School of Transdisciplinary Engineering, Pusan Nation University, Pusan, 46241, South Korea
5. Institute of Nanobio Convergence, Pusan National University, Pusan, 46241, South Korea
6. Department of Internal Medicine, Medical Research Institute, Pusan National University School of Medicine and Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan, 50612, South Korea
7. Humanoid olfactory display Innovation Research Center, Pusan National University, Pusan, 46241, South Korea
8. Research Center of Energy Convergence Technology, Pusan National University, Pusan, 46241, South Korea
9. School of Transdisciplinary Engineering, Pusan National University, Pusan, 46241, South Korea
Abstract

Introduction:

Raman spectroscopy enables label-free molecular fingerprinting of serum metabolites, but its clinical use is limited by weak signals from trace analytes and uncontrolled aggregation of gold nanoparticles (Au NPs). Here, we developed a bio–metal hybrid film (BMHF) in which human serum albumin (HSA) acts as a natural capping agent to regulate Au NP assembly and generate reproducible SERS-active nanoclusters for serum-based gastric cancer diagnosis.

Methods:

Serum was mixed with concentrated 80-nm citrate-capped Au NPs at a 1:1 volume ratio and stabilized for 1 h to form a bio–metal hybrid solution. Uniform BMHF substrates were fabricated on SiO substrates by meniscus-dragging deposition (MDD). The coating speed, blade-to-substrate gap, and HSA concentration were optimized using scanning electron microscopy and Raman spectroscopy. FDTD were conducted to assess electromagnetic-field enhancement as a function of the interparticle gap. Raman spectra were collected from serum samples of 50 gastric cancer patients and 50 controls. Spectral features in the 500–1750 cm−1 region were normalized and classified using a deep neural network optimized by Bayesian hyperparameter optimization and five-fold cross-validation.

Results and Discussion: The optimal BMHF was obtained at a coating speed of 5 mm/s, a blade-to-substrate gap of 500 µm, an HSA concentration of 100 nM, and a 1-h stabilization period. HSA suppressed irreversible Au NP aggregation while producing a uniform three-dimensional nanocluster structure with an average Au NP gap of approximately 10 nm. This gap condition was consistent with FDTD showing the greatest effective electric-field enhancement. The BMHF detected serum diluted to 1:100 and rhodamine 6G at M, and it maintained stable Raman responses over 10 days and 200 consecutive measurements. In the independent test set, the neural-network classifier achieved 96.7% sensitivity, 85.6% specificity, and an area under the receiver-operating-characteristic curve of 0.97 for discrimination between gastric cancer and  control groups.

Conclusions: The HSA-mediated BMHF provides a stable and reproducible SERS substrate by controlling Au NP assembly and maintaining accessible plasmonic hotspots. Combined with neural-network-assisted spectral classification, this label-free serum platform demonstrated high diagnostic performance for gastric cancer and has potential for blood-based metabolomic screening.

Keywords
Metabolomics; Human serum albumin; Nanostructure; Surface-enhanced Raman scattering; Machine learning classification.
Real-Time Monitoring of Cervical Movements Using Two Nodes Inertial Sensor System
Clinically Effective Scar Treatment via a Gene Silencing siRNA Nanoplex Platform Technology: From Animal and Clinical studies to Commercialization